Advertisement
Advertisement

Differences Between HIV-Infected Men and Women in Antiretroviral Therapy Outcomes -- Six African Countries, 2004-2012

November 29, 2013

 < Prev  |  1  |  2  |  3  |  4  |  5  |  6  |  Next > 

TABLE 2. Enrollment Characteristics of Adults (N = 13,175) Initiating Antiretroviral Therapy (ART) -- Six African Countries, 2004-2010

Characteristic

Côte d'Ivoire*
(N = 3,682)

Swaziland*
(N = 2,510)

Mozambique*
(N = 2,596)

No.

Median
age

p-value§

No.

Median
age

p-value

No.

Median
age

p-value

Sex, no., and median age

         

Women

2,422

34

<0.001

1,621

32

<0.001

1,576

32

<0.001

Men

1,260

40

 

889

38

 

1,020

38

 
 

No.

Median
CD4

p-value

No.

Median
CD4

p-value

No.

Median
CD4

p-value

Sex, no., and median CD4 count at ART initiation (cells/µL)

 

 

 

 

 

 

 

 

 

Women

1,811

155

<0.001

1,487

161

<0.001

1,373

161

0.063

Men

935

119

 

809

121

 

881

141

 

Missing data

936

--

 

214

--

 

342

--

 
 

No.

(%)

p-value

No.

(%)

p-value

No.

(%)

p-value

Sex, no., and %

 

 

 

 

 

 

 

 

 

Women

2,422

(67)

 

1,621

(65)

 

1,576

(62)

 

Men

1,260

(33)

 

889

(35)

 

1,020

(38)

 

WHO HIV disease stage

 

 

 

 

 

 

 

Stage I/II

         

Women

363

(19)

0.064

700

(50)

<0.001

386

(39)

0.001

Men

224

(22)

 

260

(34)

 

233

(34)

 

Stage III

  

 

      

Women

987

(61)

 

590

(40)

 

451

(48)

 

Men

453

(53)

 

377

(48)

 

288

(46)

 

Stage IV

  

 

      

Women

331

(21)

 

149

(10)

 

136

(13)

 

Men

223

(26)

 

144

(18)

 

123

(20)

 

Missing data

1,101

(30)

 

290

(12)

 

979

(38)

 

Female regimens

 

 

 

 

 

 

NVP-3TC-D4T/AZT/TDF

1,219

(49)

0.077

1,153

(72)

<0.001

1,430

(91)

<0.001

EFV-3TC-D4T/AZT/TDF

692

(30)

 

372

(23)

 

124

(8)

 

Triple NRTI

90

(3)

 

0

--

 

13

(1)

 

PI-based

122

(4)

 

0

--

 

1

(<1)

 

Unknown

211

(10)

 

96

(5)

 

8

(<1)

 

Other

88

(5)

 

0

--

 

0

--

 

Male regimens

 

 

 

 

 

 

NVP-3TC-D4T/AZT/TDF

548

(42)

 

519

(59)

 

881

(85)

 

EFV-3TC-D4T/AZT/TDF

430

(36)

 

309

(35)

 

120

(13)

 

Triple NRTI

48

(3)

 

0

--

 

4

(<1)

 

PI-based

84

(6)

 

1

(<1)

 

2

(<1)

 

Unknown

110

(9)

 

60

(6)

 

13

(1)

 

Other

40

(3)

 

0

--

 

0

--

 
 < Prev  |  1  |  2  |  3  |  4  |  5  |  6  |  Next > 



This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication Morbidity and Mortality Weekly Report. Visit the CDC's website to find out more about their activities, publications and services.
 

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement